X4 Pharmaceuticals, Inc Annual Interest Expense in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
X4 Pharmaceuticals, Inc quarterly/annual Interest Expense history and growth rate from 2016 to 2023.
  • X4 Pharmaceuticals, Inc Interest Expense for the quarter ending September 30, 2024 was $2.41M, a 47.7% increase year-over-year.
  • X4 Pharmaceuticals, Inc Interest Expense for the twelve months ending September 30, 2024 was $8.35M, a 65.8% increase year-over-year.
  • X4 Pharmaceuticals, Inc annual Interest Expense for 2023 was $5.78M, a 44.7% increase from 2022.
  • X4 Pharmaceuticals, Inc annual Interest Expense for 2022 was $3.99M, a 9.64% increase from 2021.
  • X4 Pharmaceuticals, Inc annual Interest Expense for 2021 was $3.64M, a 35.5% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.78M +$1.78M +44.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $3.99M +$351K +9.64% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $3.64M +$954K +35.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-21
2020 $2.69M +$541K +25.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-21
2019 $2.15M +$1.43M +198% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-17
2018 $720K +$230K +46.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-19
2017 $490K -$2.03M -80.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $2.52M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.